PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 32 filers reported holding PROFOUND MED CORP in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Timelo Investment Management Inc. | 673,158 | $6,866,212 | 9.03% |
Gagnon Advisors, LLC | 679,296 | $6,928,819 | 5.80% |
GAGNON SECURITIES LLC | 1,582,166 | $16,138,093 | 4.04% |
THOMPSON DAVIS & CO., INC. | 86,375 | $881,025 | 1.09% |
LETKO, BROSSEAU & ASSOCIATES INC | 1,164,125 | $11,352,296 | 0.22% |
Zweig-DiMenna Associates LLC | 87,274 | $890,195 | 0.10% |
MTM Investment Management, LLC | 19,875 | $202,725 | 0.10% |
ROYCE & ASSOCIATES LP | 569,898 | $5,714,714 | 0.06% |
Harbor Advisors LLC | 12,400 | $126,480 | 0.03% |
FIL Ltd | 1,200,635 | $12,039,498 | 0.01% |
SOA Wealth Advisors, LLC. | 4,000 | $40,800 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 550,707 | $5,617,211 | 0.01% |
NATIONAL BANK OF CANADA /FI/ | 128,141 | $1,209,877 | 0.00% |
Schonfeld Strategic Advisors LLC | 10,900 | $111,180 | 0.00% |
ROYAL BANK OF CANADA | 401,833 | $4,099,000 | 0.00% |
Cetera Advisor Networks LLC | 11,669 | $117,570 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 67,731 | $690,856 | 0.00% |
GOLDMAN SACHS GROUP INC | 19,400 | $197,880 | 0.00% |
MORGAN STANLEY | 7,734 | $78,887 | 0.00% |
BANK OF MONTREAL /CAN/ | 12,047 | $107,138 | 0.00% |
External links
This page lists PROFOUND MED CORP's shareholders in Q3 2023. To view PROFOUND MED CORP's shareholder history, click here.